Published in Diabetes on February 01, 1974
Pilot Study to Assess the Proteome in Human Atrial Tissue | NCT00591903
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) BMJ (1998) 7.48
Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) (1983) 3.28
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet (2013) 2.74
HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia (2007) 2.03
Risk factors for myocardial infarction in young women. Br J Prev Soc Med (1976) 2.01
Clinical practice guidelines for treatment of diabetes mellitus. Expert Committee of the Canadian Diabetes Advisory Board. CMAJ (1992) 1.90
Improved glucose control in maturity-onset diabetes treated with high-carbohydrate-modified fat diet. Br Med J (1979) 1.65
Concepts and controversies about the prevention of coronary heart disease. Postgrad Med J (1976) 1.50
Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes. CMAJ (2007) 1.46
Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) (1987) 1.44
Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control? Br J Pharmacol (2009) 1.41
Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax (1990) 1.34
Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats. Br J Pharmacol (1988) 1.33
Serum lipids in young female survivors of myocardial infarction. Br Heart J (1975) 1.31
Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry (1992) 1.29
The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol (1999) 1.29
Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes. Am J Physiol Heart Circ Physiol (2010) 1.24
Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice. Amino Acids (2010) 1.20
Effect of diabetes and hypertension on left ventricular diastolic function in a high-risk population without evidence of heart disease. Eur J Heart Fail (2010) 1.12
Early photocoagulation in patients with either type I or type II diabetes. Trans Am Ophthalmol Soc (1996) 1.09
High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br Med J (1978) 1.09
Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes (2015) 1.08
Coronary artery manifestations of fibromuscular dysplasia. J Am Coll Cardiol (2014) 1.04
Activation of EGFR/ERBB2 via pathways involving ERK1/2, P38 MAPK, AKT and FOXO enhances recovery of diabetic hearts from ischemia-reperfusion injury. PLoS One (2012) 1.04
Diabetes mortality in persons under 45 years of age. Am J Public Health (1983) 1.02
Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts. Cardiovasc Diabetol (2008) 1.02
Mild Type 2 Diabetes Mellitus Reduces the Susceptibility of the Heart to Ischemia/Reperfusion Injury: Identification of Underlying Gene Expression Changes. J Diabetes Res (2015) 1.01
Incidence of hypertension and non-insulin dependent diabetes mellitus and associated risk factors in a rapidly developing Caribbean community: the St James survey, Trinidad. J Epidemiol Community Health (1996) 0.98
Cardiac structure and function are altered in type 2 diabetes and non-alcoholic fatty liver disease and associate with glycemic control. Cardiovasc Diabetol (2015) 0.97
Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Nutr Metab (Lond) (2006) 0.96
Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed. Br J Pharmacol (2005) 0.95
Myocardial infarct size and mortality in diabetic patients. Br Heart J (1985) 0.93
Taking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy. J Am Heart Assoc (2013) 0.91
Reversal of mitochondrial proteomic loss in Type 1 diabetic heart with overexpression of phospholipid hydroperoxide glutathione peroxidase. Am J Physiol Regul Integr Comp Physiol (2013) 0.90
Diabetes mellitus as a risk factor for acute myocardial infarction in Asians and Europeans. Br Heart J (1989) 0.90
[Heart failure in diabetes]. Wien Med Wochenschr (2009) 0.90
In-vitro venous prostacyclin production, plasma 6-keto-prostaglandin F1 alpha concentrations, and diabetic retinopathy. Br Med J (Clin Res Ed) (1981) 0.89
Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2. Cardiovasc Diabetol (2009) 0.89
Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus. J Clin Invest (1983) 0.89
Physiological and structural differences in spatially distinct subpopulations of cardiac mitochondria: influence of cardiac pathologies. Am J Physiol Heart Circ Physiol (2014) 0.89
Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes. Diabetes (2015) 0.88
Metabolic dysfunction in diabetic cardiomyopathy. Heart Fail Rev (2014) 0.88
Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition. J Physiol (2002) 0.88
Effect of moderate-intensity exercise on plasma C-reactive protein and aortic endothelial function in type 2 diabetic mice. Mediators Inflamm (2010) 0.88
The association between extracoronary calcification and coronary artery disease in patients with type 2 diabetes mellitus. Heart Vessels (2011) 0.87
Duloxetine in the management of diabetic peripheral neuropathic pain. Patient Prefer Adherence (2011) 0.87
The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease. Prog Cardiovasc Dis (2015) 0.87
Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice. Cardiovasc Diabetol (2015) 0.86
Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects. Eur J Epidemiol (2000) 0.86
Heart failure in the diabetic population - pathophysiology, diagnosis and management. Arch Med Sci (2014) 0.86
Poor glycemic control is an independent risk factor for low HDL cholesterol in patients with type 2 diabetes. Diabetes Care (2009) 0.86
The heart in diabetes. West J Med (1984) 0.85
Diabetic hypertensive control and treatment: a descriptive report from the audit diabetes control and management (adcm) registry. Malays Fam Physician (2010) 0.85
Inflammation and cognitive dysfunction in type 2 diabetic carotid endarterectomy patients. Diabetes Care (2013) 0.85
Improvement of mechanical heart function by trimetazidine in db/db mice. Acta Pharmacol Sin (2010) 0.84
Anticardiolipin antibody levels in diabetic subjects with and without coronary artery disease. Postgrad Med J (1989) 0.84
Functional deficiencies of subsarcolemmal mitochondria in the type 2 diabetic human heart. Am J Physiol Heart Circ Physiol (2014) 0.84
Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats. Br J Pharmacol (1995) 0.84
Epidemiology of type II diabetes: an international perspective. Pharmacoeconomics (1995) 0.83
Effects of type 1 diabetes mellitus on cardiac function: a study of monozygotic twins. Br Heart J (1995) 0.83
Antioxidant N-acetylcysteine attenuates the reduction of Brg1 protein expression in the myocardium of type 1 diabetic rats. J Diabetes Res (2013) 0.83
Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence. Vasc Health Risk Manag (2009) 0.83
Relation between carotid intima media thickness and oxidative stress markers in type 1 diabetic children and adolescents. J Diabetes Metab Disord (2013) 0.83
Protein kinase C-mediated contractile responses of arteries from diabetic rats. Br J Pharmacol (1990) 0.83
Relationship between cholesterol crystals and culprit lesion characteristics in patients with stable coronary artery disease: an optical coherence tomography study. Clin Res Cardiol (2014) 0.82
Practical aspects of the control of cardiovascular risk in type 2 diabetes mellitus and the metabolic syndrome. Exp Clin Cardiol (2007) 0.82
Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes. J Am Coll Cardiol (2016) 0.81
Epidemiology of diabetes and complications among adults in the Republic of Ireland 1998-2015: a systematic review and meta-analysis. BMC Public Health (2016) 0.81
Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats. J Physiol (2002) 0.81
Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients. Lipids Health Dis (2011) 0.81
Present Insights on Cardiomyopathy in Diabetic Patients. Curr Diabetes Rev (2016) 0.81
Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study). Am J Cardiol (2008) 0.80
Alterations in connexin 43 during diabetic cardiomyopathy: competition of tyrosine nitration versus phosphorylation. J Diabetes (2014) 0.80
Guidelines adherence in the treatment of patients with newly diagnosed type 2 diabetes: a historical cohort comparing the use of metformin in Quebec pre and post-Canadian Diabetes Association guidelines. BMC Health Serv Res (2013) 0.80
Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy. Heart Fail Rev (2014) 0.79
Arterial heparan sulfate is negatively associated with hyperglycemia and atherosclerosis in diabetic monkeys. Cardiovasc Diabetol (2004) 0.79
Frequency of risk factors for coronary heart disease among diabetic patients in Al-rabwah phc center in riyadh. J Family Community Med (2004) 0.79
Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. Biomed Res Int (2016) 0.79
Angiogenic microenvironment augments impaired endothelial responses under diabetic conditions. Am J Physiol Cell Physiol (2014) 0.78
Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy. Cardiovasc Diabetol (2015) 0.78
The ethnic prevalence of hypertension in a diabetic clinic. Postgrad Med J (1983) 0.78
Assessment of whole-genome regression for type II diabetes. PLoS One (2015) 0.78
The influence of diabetes on short-term outcome following a prosthetic above-the-knee femoro-popliteal bypass. Cardiovasc J Afr (2009) 0.78
High-intensity interval training: a review of its impact on glucose control and cardiometabolic health. Diabetologia (2016) 0.78
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease. J Diabetes Res (2016) 0.78
The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation. BMC Health Serv Res (2017) 0.78
Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus. Eur Heart J (2015) 0.77
Hypertension and diabetes. Clinical problems. Drugs (1988) 0.77
Combined use of brain natriuretic peptide and C-reactive protein for predicting cardiovascular risk in outpatients with type 2 diabetes mellitus. Vasc Health Risk Manag (2007) 0.77
Glucose intolerance, diabetes mellitus and atherosclerosis; prospects for prevention. Postgrad Med J (1976) 0.77
Role of diabetes in heart rhythm disorders. World J Diabetes (2016) 0.77
What the radiologist needs to know about the diabetic patient. Insights Imaging (2011) 0.77
Can we prevent high-risk patients from getting type 2 diabetes? Can Fam Physician (2002) 0.77
Atypical presentation of acute and chronic coronary artery disease in diabetics. World J Cardiol (2014) 0.76
Telemedicine home blood pressure measurements and progression of albuminuria in elderly people with diabetes. Hypertension (2008) 0.76
Effect of acute hypoxia on cardiac function in alloxan-diabetic dogs. Basic Res Cardiol (1986) 0.76
Comparitive angiographic profile in diabetic and non-diabetic patients with acute coronary syndrome. J Clin Diagn Res (2014) 0.76
HDAC Inhibition Modulates Cardiac PPARs and Fatty Acid Metabolism in Diabetic Cardiomyopathy. PPAR Res (2016) 0.76
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation (1983) 12.63
Diabetes and cardiovascular disease. The Framingham study. JAMA (1979) 11.95
An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
The Framingham Offspring Study. Design and preliminary data. Prev Med (1975) 10.53
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med (1982) 8.62
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med (1971) 7.46
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J (1986) 5.89
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Diabetes and cardiovascular risk factors: the Framingham study. Circulation (1979) 5.32
Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol (1974) 5.11
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11
A general cardiovascular risk profile: the Framingham Study. Am J Cardiol (1976) 5.10
Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol (1972) 5.05
Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med (1984) 5.02
Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med (1979) 4.94
Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol (1971) 4.90
Some health benefits of physical activity. The Framingham Study. Arch Intern Med (1979) 4.63
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation (1977) 4.47
The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis (1966) 4.15
Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J (1987) 4.12
Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med (1970) 4.11
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care (1980) 3.70
Epidemiology of gout and hyperuricemia. A long-term population study. Am J Med (1967) 3.65
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med (1976) 3.50
Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA (1993) 3.42
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation (1990) 3.29
Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29
Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Br J Cancer (2001) 3.23
Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1999) 3.16
The recent decrease in CHD mortality. Prev Med (1975) 3.16
Premature mortality from coronary heart disease. The Framingham study. JAMA (1971) 3.15
The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med (1967) 3.05
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93
Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med (1972) 2.91
Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med (1969) 2.88
The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease. Am J Epidemiol (1980) 2.86
Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med (1987) 2.82
Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. Lancet (1974) 2.81
Labile hypertension: a faulty concept? The Framingham study. Circulation (1980) 2.76
Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation (1975) 2.74
Hearing in the elderly: the Framingham cohort, 1983-1985. Part I. Basic audiometric test results. Ear Hear (1990) 2.71
Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr (1996) 2.70
Clustering of metabolic factors and coronary heart disease. Arch Intern Med (1999) 2.69
Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA (1988) 2.68
Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet (1977) 2.66
Menopause and coronary heart disease. The Framingham Study. Ann Intern Med (1978) 2.62
Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med (1988) 2.62
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 2.60
The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. JAMA (1988) 2.59
The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol (1997) 2.58